DBD
Diebold Nixdorf, Incorporated
NYSE · USTechnologySoftware - Application
$85.34-0.39%
Price as of Jul 20, 2026
DBD growth
Diebold Nixdorf, Incorporated growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +4.3%
- EBITDA
- -4.3%
- EBIT
- +60.9%
- EPS
- +1207.4%
- Free cash flow
- +46.4%
- Operating cash flow
- +68.1%
Forward estimates
- Revenue
- +2.2%
- EBITDA
- +91.3%
- EPS
- +109.7%
Three-year CAGR
- Revenue
- +3.2%
- EBITDA
- +10.3%
- EBIT
- +96.2%
- Net income
- -73.8%
- EPS
- -65.3%
- Free cash flow
- +99.8%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.